The proteasome: structure, function, and role in the cell - PubMed (original) (raw)
Review
The proteasome: structure, function, and role in the cell
Julian Adams. Cancer Treat Rev. 2003 May.
Abstract
The proteasome is a multisubunit enzyme complex that plays a central role in the regulation of proteins that control cell-cycle progression and apoptosis, and has therefore become an important target for anticancer therapy. Before a protein is degraded, it is first flagged for destruction by the ubiquitin conjugation system, which ultimately results in the attachment of a polyubiquitin chain on the target protein. The proteasome's 19S regulatory cap binds the polyubiquitin chain, denatures the protein, and feeds the protein into the proteasome's proteolytic core. The proteolytic core is composed of 2 inner beta rings and 2 outer alpha rings. The 2 beta rings each contain 3 proteolytic sites named for their trypsin-like, post-glutamyl peptide hydrolase-like (PGPH) (i.e., caspase-like), or chymotrypsin-like activity. Inhibition of the proteasome results in cell-cycle arrest and apoptosis. In in vitro and in vivo animal studies, inhibition of the proteasome via bortezomib (VELCADE; formerly, PS-341, LDP-341, and MLN341) had antitumor activity against numerous tumor types either alone or in combination with conventional chemotherapeutic agents; these results provided the rationale for a broad clinical trial program. Bortezomib is currently in phase III trials for myeloma and is in early clinical development for numerous other tumor types.
Similar articles
- Development of the proteasome inhibitor Velcade (Bortezomib).
Adams J, Kauffman M. Adams J, et al. Cancer Invest. 2004;22(2):304-11. doi: 10.1081/cnv-120030218. Cancer Invest. 2004. PMID: 15199612 Review. - Clinical update: proteasome inhibitors in solid tumors.
Lenz HJ. Lenz HJ. Cancer Treat Rev. 2003 May;29 Suppl 1:41-8. doi: 10.1016/s0305-7372(03)00082-3. Cancer Treat Rev. 2003. PMID: 12738242 Review. - Proteasome inhibitors as new anticancer drugs.
Adams J. Adams J. Curr Opin Oncol. 2002 Nov;14(6):628-34. doi: 10.1097/00001622-200211000-00007. Curr Opin Oncol. 2002. PMID: 12409653 Review. - Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib.
Cusack JC. Cusack JC. Cancer Treat Rev. 2003 May;29 Suppl 1:21-31. doi: 10.1016/s0305-7372(03)00079-3. Cancer Treat Rev. 2003. PMID: 12738240 Review. - Potential for proteasome inhibition in the treatment of cancer.
Adams J. Adams J. Drug Discov Today. 2003 Apr 1;8(7):307-15. doi: 10.1016/s1359-6446(03)02647-3. Drug Discov Today. 2003. PMID: 12654543 Review.
Cited by
- Plant U-box E3 ligases PUB20 and PUB21 negatively regulate pattern-triggered immunity in Arabidopsis.
Yi SY, Nekrasov V, Ichimura K, Kang SY, Shirasu K. Yi SY, et al. Plant Mol Biol. 2024 Jan 24;114(1):7. doi: 10.1007/s11103-023-01409-6. Plant Mol Biol. 2024. PMID: 38265485 - Protein homeostasis as a therapeutic target for diseases of protein conformation.
Calamini B, Morimoto RI. Calamini B, et al. Curr Top Med Chem. 2012;12(22):2623-40. doi: 10.2174/1568026611212220014. Curr Top Med Chem. 2012. PMID: 23339312 Free PMC article. Review. - New applications of old metal-binding drugs in the treatment of human cancer.
Schmitt SM, Frezza M, Dou QP. Schmitt SM, et al. Front Biosci (Schol Ed). 2012 Jan 1;4(1):375-91. doi: 10.2741/274. Front Biosci (Schol Ed). 2012. PMID: 22202066 Free PMC article. Review. - A new gold(I) complex-Au(PPh3)PT is a deubiquitinase inhibitor and inhibits tumor growth.
Li X, Huang Q, Long H, Zhang P, Su H, Liu J. Li X, et al. EBioMedicine. 2019 Jan;39:159-172. doi: 10.1016/j.ebiom.2018.11.047. Epub 2018 Dec 5. EBioMedicine. 2019. PMID: 30527624 Free PMC article. - Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.
Loureiro J, Ploegh HL. Loureiro J, et al. Adv Immunol. 2006;92:225-305. doi: 10.1016/S0065-2776(06)92006-9. Adv Immunol. 2006. PMID: 17145306 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous